サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606373

ナノバイオテクノロジー市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測

Nano-Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 176 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ナノバイオテクノロジー市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測
出版日: 2024年10月28日
発行: Transparency Market Research
ページ情報: 英文 176 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナノバイオテクノロジー市場- 調査範囲

TMRの調査レポート「ナノバイオテクノロジーの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のナノバイオテクノロジー市場の収益と予測を提供しています。また、2024年から2034年までの世界のナノバイオテクノロジー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、ナノバイオテクノロジー市場を推察しました。

市場スナップショット
2023年の市場規模 1,575億米ドル
2034年の市場規模 4,215億米ドル
CAGR 9.3%

当レポートでは、世界のナノバイオテクノロジー市場の競合情勢について調査しています。世界のナノバイオテクノロジー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介している世界のナノバイオテクノロジー市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020～2034年

第5章 主要洞察

  • 産業界における昨今の技術進歩
  • 特許分析
  • 主要地域/国における規制状況
  • ポーターのファイブフォース分析
  • PEST分析
  • 主要な業界イベント（製品承認、パートナーシップ、コラボレーション）

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/ 開発
  • 市場金額予測：製品タイプ別、2020～2034年
    • ナノマテリアル
    • デバイス
    • 試薬
  • 製品タイプ別の市場の魅力

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/ 開発
  • 市場金額予測：用途別、2020～2034年
    • ドラッグデリバリー
    • 診断
    • イメージング
    • 遺伝子送達
    • 組織工学
    • その他
  • 用途別の市場の魅力

第8章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/ 開発
  • 市場金額予測：エンドユーザー別、2020～2034年
    • 製薬・バイオ医薬品企業
    • 学術調査室
    • その他
  • エンドユーザー別の市場の魅力

第9章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場の魅力

第10章 北米の市場分析と予測

  • 米国
  • カナダ

第11章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域

第12章 アジア太平洋地域の市場分析と予測

  • 中国
  • 日本
  • インド
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第13章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第14章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第15章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別, 2023年
  • 企業プロファイル
    • Johnson & Johnson Services, Inc.
    • Abbott
    • Novartis AG
    • Merck and Co. Inc.
    • Bristol-Myers Squibb Company
    • Danaher Corporation
    • Thermo Fisher Scientific, Inc.
    • Pfizer, Inc.
図表

List of Tables

  • Table 01: Global Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 02: Global Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 03: Global Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 04: Global Nano-biotechnology Market Value (US$ Bn) Forecast, by Region, 2020-2034
  • Table 05: North America Nano-biotechnology Market Value (US$ Bn) Forecast, by Country, 2020-2034
  • Table 06: North America Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 07: North America Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 08: North America Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Nano-biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 11: Europe Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 12: Europe Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 15: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Nano-biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 19: Latin America Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Forecast, by Product Type, 2020-2034
  • Table 23: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Nano-biotechnology Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 02: Global Nano-biotechnology Market Value Share, by Product Type, 2023
  • Figure 03: Global Nano-biotechnology Market Value Share, by Application, 2023
  • Figure 04: Global Nano-biotechnology Market Value Share, by End-user, 2023
  • Figure 05: Global Nano-biotechnology Market Value Share, by Region, 2023
  • Figure 06: Global Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 07: Global Nano-biotechnology Market Share Analysis, by Product Type, 2023
  • Figure 08: Global Nano-biotechnology Market Share Analysis, by Product Type, 2034
  • Figure 09: Global Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 10: Global Nano-biotechnology Market Value (US$ Bn), by Nanomaterials, 2020-2034
  • Figure 11: Global Nano-biotechnology Market Value Share Analysis, by Nanomaterials, 2023 and 2034
  • Figure 12: Global Nano-biotechnology Market Value (US$ Bn), by Devices, 2020-2034
  • Figure 13: Global Nano-biotechnology Market Value Share Analysis, by Devices, 2023 and 2034
  • Figure 14: Global Nano-biotechnology Market Value (US$ Bn), by Reagents, 2020-2034
  • Figure 15: Global Nano-biotechnology Market Value Share Analysis, by Reagents, 2023 and 2034
  • Figure 16: Global Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 17: Global Nano-biotechnology Market Share Analysis, by Application, 2023
  • Figure 18: Global Nano-biotechnology Market Share Analysis, by Application, 2034
  • Figure 19: Global Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 20: Global Nano-biotechnology Market Value (US$ Bn), by Drug Delivery, 2020-2034
  • Figure 21: Global Nano-biotechnology Market Value Share Analysis, by Drug Delivery, 2023 and 2034
  • Figure 22: Global Nano-biotechnology Market Value (US$ Bn), by Diagnostics, 2020-2034
  • Figure 23: Global Nano-biotechnology Market Value Share Analysis, by Diagnostics, 2023 and 2034
  • Figure 24: Global Nano-biotechnology Market Value (US$ Bn), by Imaging, 2020-2034
  • Figure 25: Global Nano-biotechnology Market Value Share Analysis, by Imaging, 2023 and 2034
  • Figure 26: Global Nano-biotechnology Market Value (US$ Bn), by Gene Delivery, 2020-2034
  • Figure 27: Global Nano-biotechnology Market Value Share Analysis, by Gene Delivery, 2023 and 2034
  • Figure 28: Global Nano-biotechnology Market Value (US$ Bn), by Tissue Engineering, 2020-2034
  • Figure 29: Global Nano-biotechnology Market Value Share Analysis, by Tissue Engineering, 2023 and 2034
  • Figure 30: Global Nano-biotechnology Market Value (US$ Bn), by Others, 2020-2034
  • Figure 31: Global Nano-biotechnology Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 32: Global Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Global Nano-biotechnology Market Share Analysis, by End-user, 2023
  • Figure 34: Global Nano-biotechnology Market Share Analysis, by End-user, 2034
  • Figure 35: Global Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Global Nano-biotechnology Market Value (US$ Bn), by Pharmaceutical and Biopharmaceutical Companies, 2020-2034
  • Figure 37: Global Nano-biotechnology Market Value Share Analysis, by Pharmaceutical and Biopharmaceutical Companies, 2023 and 2034
  • Figure 38: Global Nano-biotechnology Market Value (US$ Bn), by Academic and Research Laboratories, 2020-2034
  • Figure 39: Global Nano-biotechnology Market Value Share Analysis, by Academic and Research Laboratories, 2023 and 2034
  • Figure 40: Global Nano-biotechnology Market Value (US$ Bn), by Others, 2020-2034
  • Figure 41: Global Nano-biotechnology Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 42: Global Nano-biotechnology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 43: Global Nano-biotechnology Market Share Analysis, by Region, 2023
  • Figure 44: Global Nano-biotechnology Market Share Analysis, by Region, 2034
  • Figure 45: Global Nano-biotechnology Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 46: North America Nano-biotechnology Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 47: North America Nano-biotechnology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 48: North America Nano-biotechnology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 49: North America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 50: North America Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 51: North America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 52: North America Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: North America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 54: North America Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 55: Europe Nano-biotechnology Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Europe Nano-biotechnology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Europe Nano-biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Europe Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 59: Europe Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 60: Europe Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 61 Europe Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 62: Europe Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 63: Europe Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 64: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 65: Asia Pacific Nano-biotechnology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 66: Asia Pacific Nano-biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 67: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 68: Asia Pacific Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 69: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 70: Asia Pacific Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 71: Asia Pacific Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 72: Asia Pacific Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 73: Latin America Nano-biotechnology Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 74: Latin America Nano-biotechnology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 75: Latin America Nano-biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 76: Latin America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 77: Latin America Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 78: Latin America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 79: Latin America Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 80: Latin America Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 81: Latin America Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 82: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 83: Middle East & Africa Nano-biotechnology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 84: Middle East & Africa Nano-biotechnology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 85: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034
  • Figure 86: Middle East & Africa Nano-biotechnology Market Attractiveness Analysis, by Product Type, 2024-2034
  • Figure 87: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034
  • Figure 88: Middle East & Africa Nano-biotechnology Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 89: Middle East & Africa Nano-biotechnology Market Value (US$ Bn) Share Analysis, by End-user, 2023 and 2034
  • Figure 90: Middle East & Africa Nano-biotechnology Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL788

Nano-biotechnology Market - Scope of Report

TMR's report on the global nano-biotechnology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nano-biotechnology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nano-biotechnology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nano-biotechnology market.

Market Snapshot
Market Value in 2023US$ 157.5 Bn
Market Value in 2034US$ 421.5 Bn
CAGR9.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nano-biotechnology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nano-biotechnology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nano-biotechnology market.

The report delves into the competitive landscape of the global nano-biotechnology market. Key players operating in the global nano-biotechnology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nano-biotechnology market profiled in this report.

Key Questions Answered in Global nano-biotechnology Market Report:

  • What is the sales/revenue generated by nano-biotechnology across all regions during the forecast period?
  • What are the opportunities in the global nano-biotechnology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nano-biotechnology Market - Research Objectives and Research Approach

The comprehensive report on the global nano-biotechnology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nano-biotechnology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nano-biotechnology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Nano-Biotechnology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nano-Biotechnology Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Recent Technological Advancements in Nano-biotechnology Industry
  • 5.2. Patent Analysis
  • 5.3. Regulatory Landscape across Key Regions / Countries
  • 5.4. Porter's Five Forces Analysis
  • 5.5. PEST Analysis
  • 5.6. Key Industry Events (Product Approvals, Partnerships, and Collaborations)

6. Global Nano-Biotechnology Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2034
    • 6.3.1. Nanomaterials
    • 6.3.2. Devices
    • 6.3.3. Reagents
  • 6.4. Market Attractiveness By Product Type

7. Global Nano-Biotechnology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Drug Delivery
    • 7.3.2. Diagnostics
    • 7.3.3. Imaging
    • 7.3.4. Gene Delivery
    • 7.3.5. Tissue Engineering
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Nano-Biotechnology Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020-2034
    • 8.3.1. Pharmaceutical and Biopharmaceutical Companies
    • 8.3.2. Academic and Research Laboratories
    • 8.3.3. Others
  • 8.4. Market Attractiveness By End-user

9. Global Nano-Biotechnology Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Nano-Biotechnology Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2034
    • 10.2.1. Nanomaterials
    • 10.2.2. Devices
    • 10.2.3. Reagents
  • 10.3. Market Value Forecast By Application, 2020-2034
    • 10.3.1. Drug Delivery
    • 10.3.2. Diagnostics
    • 10.3.3. Imaging
    • 10.3.4. Gene Delivery
    • 10.3.5. Tissue Engineering
    • 10.3.6. Others
  • 10.4. Market Value Forecast By End-user, 2020-2034
    • 10.4.1. Pharmaceutical and Biopharmaceutical Companies
    • 10.4.2. Academic and Research Laboratories
    • 10.4.3. Others
  • 10.5. Market Value Forecast By Country, 2020-2034
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Nano-Biotechnology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2034
    • 11.2.1. Nanomaterials
    • 11.2.2. Devices
    • 11.2.3. Reagents
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Drug Delivery
    • 11.3.2. Diagnostics
    • 11.3.3. Imaging
    • 11.3.4. Gene Delivery
    • 11.3.5. Tissue Engineering
    • 11.3.6. Others
  • 11.4. Market Value Forecast By End-user, 2020-2034
    • 11.4.1. Pharmaceutical and Biopharmaceutical Companies
    • 11.4.2. Academic and Research Laboratories
    • 11.4.3. Others
  • 11.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Nano-Biotechnology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2034
    • 12.2.1. Nanomaterials
    • 12.2.2. Devices
    • 12.2.3. Reagents
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Drug Delivery
    • 12.3.2. Diagnostics
    • 12.3.3. Imaging
    • 12.3.4. Gene Delivery
    • 12.3.5. Tissue Engineering
    • 12.3.6. Others
  • 12.4. Market Value Forecast By End-user, 2020-2034
    • 12.4.1. Pharmaceutical and Biopharmaceutical Companies
    • 12.4.2. Academic and Research Laboratories
    • 12.4.3. Others
  • 12.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Nano-Biotechnology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2034
    • 13.2.1. Nanomaterials
    • 13.2.2. Devices
    • 13.2.3. Reagents
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Drug Delivery
    • 13.3.2. Diagnostics
    • 13.3.3. Imaging
    • 13.3.4. Gene Delivery
    • 13.3.5. Tissue Engineering
    • 13.3.6. Others
  • 13.4. Market Value Forecast By End-user, 2020-2034
    • 13.4.1. Pharmaceutical and Biopharmaceutical Companies
    • 13.4.2. Academic and Research Laboratories
    • 13.4.3. Others
  • 13.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Nano-Biotechnology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2034
    • 14.2.1. Nanomaterials
    • 14.2.2. Devices
    • 14.2.3. Reagents
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Drug Delivery
    • 14.3.2. Diagnostics
    • 14.3.3. Imaging
    • 14.3.4. Gene Delivery
    • 14.3.5. Tissue Engineering
    • 14.3.6. Others
  • 14.4. Market Value Forecast By End-user, 2020-2034
    • 14.4.1. Pharmaceutical and Biopharmaceutical Companies
    • 14.4.2. Academic and Research Laboratories
    • 14.4.3. Others
  • 14.5. Market Value Forecast By Country / Sub-region, 2020-2034
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Johnson & Johnson Services, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Abbott
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Novartis AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Merck and Co. Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Bristol-Myers Squibb Company
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Danaher Corporation
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Thermo Fisher Scientific, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Pfizer, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments